[Effect of the light regime and electromagnetic fields on mammary carcinogenesis in female rats]. 1996

V N Anisimov, and O V Zhukova, and D Sh Veniashvili, and V G Bilanishvili, and M Z Menabde, and D Gupta
Tubingen University, Germany.

Outbred female rats from the age of 1 month were kept at rooms with 12 h light: 12 h dark (LD), 24 h light (LL) and 24 h dark (DD) regimens and 2 weeks later were exposed to 3 weekly i.v. injections of NMU at the dose of 50 mg/kg and starting in 2 days after first NMU administration-to variable or static magnetic fields (VMF and SMF). Exposure to LL regimen significantly promoted whereas the exposure to DD regimen significantly inhibited NMU-induced mammary carcinogenesis. RIA of serum samples from rats maintained under different light regimens has shown that exposure to LL followed by decrease of melatonin level and increase of prolactin level at all of modifying factors (NMU, VMF, SMF). Surgical light deprivation inhibits NMU-indiced mammary carcinogenesis in female rats. The primary role of pineal function in the modifying effects of light/dark regimens and electromagnetic fields on mammary carcinogenesis are suggested.

UI MeSH Term Description Entries
D008027 Light That portion of the electromagnetic spectrum in the visible, ultraviolet, and infrared range. Light, Visible,Photoradiation,Radiation, Visible,Visible Radiation,Photoradiations,Radiations, Visible,Visible Light,Visible Radiations
D008325 Mammary Neoplasms, Experimental Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS. Experimental Mammary Neoplasms,Neoplasms, Experimental Mammary,Experimental Mammary Neoplasm,Mammary Neoplasm, Experimental,Neoplasm, Experimental Mammary
D008550 Melatonin A biogenic amine that is found in animals and plants. In mammals, melatonin is produced by the PINEAL GLAND. Its secretion increases in darkness and decreases during exposure to light. Melatonin is implicated in the regulation of SLEEP, mood, and REPRODUCTION. Melatonin is also an effective antioxidant.
D008770 Methylnitrosourea A nitrosourea compound with alkylating, carcinogenic, and mutagenic properties. Nitrosomethylurea,N-Methyl-N-nitrosourea,NSC-23909,N Methyl N nitrosourea,NSC 23909,NSC23909
D009381 Neoplasms, Radiation-Induced Tumors, cancer or other neoplasms produced by exposure to ionizing or non-ionizing radiation. Radiation-Induced Cancer,Cancer, Radiation-Induced,Radiation-Induced Neoplasms,Cancer, Radiation Induced,Cancers, Radiation-Induced,Neoplasm, Radiation-Induced,Neoplasms, Radiation Induced,Radiation Induced Cancer,Radiation Induced Neoplasms,Radiation-Induced Cancers,Radiation-Induced Neoplasm
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D003043 Cocarcinogenesis The combination of two or more different factors in the production of cancer. Cocarcinogeneses
D003624 Darkness The absence of light. Darknesses

Related Publications

V N Anisimov, and O V Zhukova, and D Sh Veniashvili, and V G Bilanishvili, and M Z Menabde, and D Gupta
September 1995, Carcinogenesis,
V N Anisimov, and O V Zhukova, and D Sh Veniashvili, and V G Bilanishvili, and M Z Menabde, and D Gupta
January 1993, Voprosy onkologii,
V N Anisimov, and O V Zhukova, and D Sh Veniashvili, and V G Bilanishvili, and M Z Menabde, and D Gupta
January 2007, Neoplasma,
V N Anisimov, and O V Zhukova, and D Sh Veniashvili, and V G Bilanishvili, and M Z Menabde, and D Gupta
October 1964, Cancer research,
V N Anisimov, and O V Zhukova, and D Sh Veniashvili, and V G Bilanishvili, and M Z Menabde, and D Gupta
April 1983, Environmental health perspectives,
V N Anisimov, and O V Zhukova, and D Sh Veniashvili, and V G Bilanishvili, and M Z Menabde, and D Gupta
December 2003, Cancer letters,
V N Anisimov, and O V Zhukova, and D Sh Veniashvili, and V G Bilanishvili, and M Z Menabde, and D Gupta
January 1991, Voprosy onkologii,
V N Anisimov, and O V Zhukova, and D Sh Veniashvili, and V G Bilanishvili, and M Z Menabde, and D Gupta
January 1994, Oncology,
V N Anisimov, and O V Zhukova, and D Sh Veniashvili, and V G Bilanishvili, and M Z Menabde, and D Gupta
May 2000, Breast cancer research and treatment,
V N Anisimov, and O V Zhukova, and D Sh Veniashvili, and V G Bilanishvili, and M Z Menabde, and D Gupta
January 1992, Revista do Hospital das Clinicas,
Copied contents to your clipboard!